Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immuno-oncology
Pharma
Leqembi, Takeda, Fujifilm Diosynth—Fierce Pharma Asia
Medicare's spending projection on Leqembi is way higher than Eisai's own estimates. Takeda partnered with Kumquat. Fujifilm restructured a CDMO unit.
Angus Liu
Apr 19, 2024 9:20am
AACR: Detailed data spark hope for Merck combo in NSCLC
Apr 9, 2024 1:16pm
AstraZeneca’s Imfinzi tackles another type of lung cancer
Apr 5, 2024 10:22am
BMS shoots for 1L liver cancer again with Opdivo, Yervoy combo
Mar 20, 2024 10:18am
AZ, GSK make case for broad I-O uses in endometrial cancer
Mar 18, 2024 11:05am
BeiGene finally snags FDA approval for PD-1 drug Tevimbra
Mar 15, 2024 8:39am